Skip to main content

Alibaba Group agrees to sell several Tmall healthcare categories to subsidiary Alibaba Health

Alibaba Group announced today that it has agreed to sell several of the healthcare categories on Tmall, its B2C shopping platform, to digital healthcare subsidiary Alibaba Health Information Technology. In exchange, Alibaba Group will receive $10.6 billion HKD (about $1.35 billion) in newly issued shares of Alibaba Health and increase its equity stake in the company, which is listed on the Hong Kong stock exchange, from 48.1% to 56.2%.

If you have followed Alibaba Group for a while and this news is giving you a feeling of déjà vu, there’s a reason why. In April 2015, Alibaba Group made a similar announcement, saying that it had agreed to integrate Tmall’s pharmacy business into Alibaba Health in exchange for a majority stake.

The next year, however, Alibaba Health disclosed to the Hong Kong Stock Exchange that it had let the proposed deal lapse because of regulatory uncertainties as the Chinese government reviewed legislation related to online drug sales. In that disclosure, it also said that Alibaba Group “continues to support [Alibaba Health] to execute an organic growth and investment strategy as the healthcare flagship company for Alibaba Group,” with the two companies exploring service agreements between Tmall and Alibaba Health.

While the deal announced today is still subject to shareholder and regulatory approval, it furthers Alibaba Group’s goal of consolidating more of Tmall’s pharmacy and healthcare business operations into Alibaba Health. These include Tmall categories like medical devices and healthcare products and medical services, which in total cover 3,300 vendors and generated 20.6 billion RMB (about $3.2 billion) in gross merchandise volume in the fiscal year that ended in March.

Vendors moving over to Alibaba Health will now have access to its ecosystem, including data analytics, hospitals, doctors, healthcare consultants and equipment suppliers, creating more growth and synergy opportunities, an Alibaba spokesperson told TechCrunch.

In a press statement, Daniel Zhang said “Healthcare is a strategically important area for Alibaba Group with strong growth potential. This transaction is a logical evolution for the continued development of Alibaba Health into our healthcare flagship platform.”



from TechCrunch https://ift.tt/2L4v25M
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Max Q: Psyche(d)

In this issue: SpaceX launches NASA asteroid mission, news from Relativity Space and more. © 2023 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/h6Kjrde via IFTTT
Post a Comment
Read more

Max Q: Anomalous

Hello and welcome back to Max Q! Last week wasn’t the most successful for spaceflight missions. We’ll get into that a bit more below. In this issue: First up, a botched launch from Virgin Orbit… …followed by one from ABL Space Systems News from Rocket Lab, World View and more Virgin Orbit’s botched launch highlights shaky financial future After Virgin Orbit’s launch failure last Monday, during which the mission experienced an  “anomaly” that prevented the rocket from reaching orbit, I went back over the company’s financials — and things aren’t looking good. For Virgin Orbit, this year has likely been completely turned on its head. The company was aiming for three launches this year, but everything will remain grounded until the cause of the anomaly has been identified and resolved. It’s unclear how long that will take, but likely at least three months. Add this delay to Virgin’s dwindling cash reserves and you have a foundation that’s suddenly much shakier than before. ...
Post a Comment
Read more

What’s Stripe’s deal?

Welcome to  The Interchange ! If you received this in your inbox, thank you for signing up and your vote of confidence. If you’re reading this as a post on our site, sign up  here  so you can receive it directly in the future. Every week, I’ll take a look at the hottest fintech news of the previous week. This will include everything from funding rounds to trends to an analysis of a particular space to hot takes on a particular company or phenomenon. There’s a lot of fintech news out there and it’s my job to stay on top of it — and make sense of it — so you can stay in the know. —  Mary Ann Stripe eyes exit, reportedly tried raising at a lower valuation The big news in fintech this week revolved around payments giant Stripe . On January 26, my Equity Podcast co-host and overall amazingly talented reporter Natasha Mascarenhas and I teamed up to write about how Stripe had set a 12-month deadline for itself to go public, either through a direct listing or by pursuin...
Post a Comment
Read more